K
Kumar Dharmarajan
Researcher at Yale University
Publications - 106
Citations - 7667
Kumar Dharmarajan is an academic researcher from Yale University. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 31, co-authored 103 publications receiving 6560 citations. Previous affiliations of Kumar Dharmarajan include Peking Union Medical College & Harvard University.
Papers
More filters
Journal ArticleDOI
Procedure Intensity and the Cost of Care
Serene I. Chen,Kumar Dharmarajan,Nancy Kim,Kelly M. Strait,Shu-Xia Li,Kyan C. Safavi,Peter K. Lindenauer,Harlan M. Krumholz,Tara Lagu +8 more
TL;DR: Among patients who do not receive invasive procedures, the cost of HF hospitalization is higher in more procedure-intense hospitals compared with hospitals that perform fewer procedures.
Journal ArticleDOI
Risk of Readmission After Discharge From Skilled Nursing Facilities Following Heart Failure Hospitalization: A Retrospective Cohort Study.
Himali Weerahandi,Li Li,Haikun Bao,Jeph Herrin,Kumar Dharmarajan,Joseph S. Ross,Kunhee Lucy Kim,Simon Jones,Leora I. Horwitz +8 more
TL;DR: Evidence suggests that interventions to reduce readmissions may be more effective if they also incorporate the SNF-to-home transition, and the hazard rate of readmission after SNF discharge following HF hospitalization is highest during the first 2 days home.
Journal ArticleDOI
Quality of Care in Chinese Hospitals: Processes and Outcomes After ST-segment Elevation Myocardial Infarction.
Nicholas S. Downing,Yongfei Wang,Kumar Dharmarajan,Sudhakar V. Nuti,Karthik Murugiah,Xue Du,Xin Zheng,Xi Li,Jing Li,Frederick A. Masoudi,John A. Spertus,Lixin Jiang,Harlan M. Krumholz +12 more
TL;DR: Higher rates of guideline‐recommended care and a decline in variation between hospitals are indicative of an improvement in quality in China, and quality improvement initiatives should focus on eliminating residual variation.
Journal ArticleDOI
Contraindicated Initiation of β-Blocker Therapy in Patients Hospitalized forHeart Failure
Kumar Dharmarajan,Kumar Dharmarajan,Frederick A. Masoudi,John A. Spertus,Shu-Xia Li,Harlan M. Krumholz +5 more
Journal ArticleDOI
Evaluating Readmission-Need for More Clarity on Methods.
TL;DR: While declining readmission rates and modestly rising postdischarge mortality rates for HF across hospitals from 2008 through 2014 were found, it was found that individual hospitals with declining readmissions rates were more likely to have, if anything, declining mortalityrates.